AWM
CLVS

Avior Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Avior Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,740
Closed -$192K – 871
2019
Q1 		$192K Buy
+7,740
New +$194K 0.04% 346
2018
Q4 		– Sell
-1,840
Closed -$54K – 773
2018
Q3 		$54K Hold
1,840
– – 0.01% 481
2018
Q2 		$84K Buy
+1,840
New +$89.5K 0.02% 454
2017
Q1 		– Sell
-100
Closed -$4K – 536
2016
Q4 		$4K Hold
100
– – ﹤0.01% 416
2016
Q3 		$4K Hold
100
– – ﹤0.01% 400
2016
Q2 		$1K Hold
100
– – ﹤0.01% 451
2016
Q1 		$2K Hold
100
– – ﹤0.01% 450
2015
Q4 		$4K Buy
+100
New +$6.45K ﹤0.01% 382

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Avior Wealth Management's CLVS Position: Q2 2019 in Review

Avior Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 7,740 shares — an estimated $192K sold.

Avior Wealth Management first reported a position in CLVS in Q4 2015 and held it in 8 quarters. The position peaked at $192K in Q1 2019. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

  • Avior Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
  • Avior Wealth Management sold 7,740 Clovis Oncology, Inc. shares in Q2 2019, an estimated $192K.
  • Avior Wealth Management first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 8 quarters.
  • Avior Wealth Management's Clovis Oncology, Inc. position peaked at $192K in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Avior Wealth Management's 13F filing for Q2 2019, filed 14 Aug 2019.